Read More 2 minute read Pharma Industry News Alexion Pharmaceuticals to acquire Syntimmune for $1.2bn to boost rare disease drug pipeline In a significant move within the pharmaceutical industry, Alexion Pharmaceuticals, a leading global biopharma company, has announced its… bypharmanewsdailySeptember 30, 2018
